Repurposing FDA-approved drugs for COVID-19: targeting the main protease through multi-phase in silico approach. Metwaly AM, Elkaeed EB, Alsfouk AA, Ibrahim IM, et al. Antivir Ther 2024;29:13596535241305536.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Metwaly AM, Elkaeed EB, Alsfouk AA, Ibrahim IM, et al. Repurposing FDA-approved drugs for COVID-19: targeting the main protease through multi-phase in silico approach. Antivir Ther 2024;29:13596535241305536.
PMID: 39639531